Nerve growth factor induces innervation and epidermal hyperplasia in in£ammatory skin diseases like psoriasis. Nerve growth factor production by keratinocytes is increased in the in£ammatory lesions. Nerve growth factor induces histamine release from mast cells. We examined the in vitro e¡ects of histamine on nerve growth factor production in human keratinocytes. Histamine enhanced nerve growth factor secretion, mRNA expression, and promoter activity in keratinocytes. Two TPA-response elements on the nerve growth factor promoter were responsible for the activation by histamine. Histamine enhanced transcriptional activity and DNA binding of activator protein 1 at the two TPAresponse elements. It shifted the TPA-response-elementbinding activator protein 1 composition from c-Jun homodimers to c-Fos/c-Jun heterodimers. Histamine transiently induced c-Fos mRNA expression, which was not detectable in unstimulated keratinocytes, whereas c-Jun mRNA expression was constitutive and was not altered by histamine. Histamine-induced enhancement of nerve growth factor secretion, promoter activity, activator protein 1 transcriptional activity, and c-Fos expression was suppressed by H1 antagonist pyrilamine, protein kinase C inhibitor calphostin C, and PD98059, an inhibitor of mitogen-activated protein kinase kinase 1. Histamine induced the translocation of protein kinase C activity from cytosol to membrane, which was suppressed by phospholipase C inhibitor U73122. It stimulated the phosphorylation of extracellular signal-regulated kinase, which was blocked by pyrilamine, calphostin C, and PD98059. These results suggest that histamine may enhance nerve growth factor production by inducing c-Fos expression in keratinocytes. These e¡ects may be mediated by the H1-receptor-induced signaling cascade of phospholipase CÀprotein kinase CÀmitogen-activated protein kinase kinase 1Àextracellular signal-regulated kinase. Key words: activator protein 1/c-Fos/extracellular signal-regulated kinase/H1 receptor/protein kinase C. J Invest Dermatol 121: 570^577, 2003 N erve growth factor (NGF) plays an important role in the development of in£ammatory skin diseases like psoriasis, atopic dermatitis, or allergic contact dermatitis (Raychaudhuri et al, 1998; Kinkelin et al, 2000; Toyoda et al, 2002) . In these skin diseases, NGF production in keratinocytes is enhanced (Raychaudhuri et al, 1998; Kinkelin et al, 2000; Toyoda et al, 2002) . NGF potentiates the proliferation of neurons, which may result in hyperinnervation and itch sensation in in£ammatory skin diseases (Kinkelin et al, 2000) . NGF also enhances the growth of keratinocytes having the high a⁄nity NGF receptor trkE (Di Marco et al, 1993; Pincelli et al, 1994) , which may lead to epidermal hyperplasia associated with psoriasis or atopic dermatitis (Toyoda et al, 2002) .
NGF also promotes the histamine release of mast cells (Bruni et al, 1982; Pearce and Thompson, 1986; Matsuda et al, 1991; Horigome et al, 1993; . In the early phases of psoriasis or atopic dermatitis, mast cells are increased in the dermis (Jiang et al, 2001; Alenius et al, 2002) . Mast cell-derived histamine induces keratinocytes to produce various in£ammatory cytokines or chemokines such as interleukin-6 or interleukin-8 (Kohda et al, 2002) . It is thus plausible that histamine may also induce NGF production in keratinocytes. A previous study reported that histamine in vitro enhanced NGF production by murine transformed keratinocytes PAM212 and 3T3 ¢broblasts (Matsuda et al, 1998) . It is unknown, however, what level of NGF production, i.e. translational or transcriptional, histamine may potentiate. In addition, previous studies did not show intracellular signaling events responsible for the NGF potentiation by histamine.
Histamine binds to cell surface receptors coupling to guanine nucleotide-binding protein (G-protein) and induces various intracellular signaling pathways. Four isotypes of histamine receptors have been identi¢ed: H1, H2, H3, and H4 receptors (Oda et al, 2000) . H1 receptor is linked to the activation of phospholipase C (PLC), which generates diacylglycerol activating protein kinase C (PKC) (Megson et al, 2001) . Stimulation of H2 receptor mostly activates adenylate cyclase, which generates a cAMP signal that activates protein kinase A; however, H2 receptor is also linked to PLC in certain cell types (Del Valle and Ganz, 1997) . H3 and H4 receptors are coupled to the inhibition of adenylate cyclase (Coge et al, 2001) . These histamine-receptor-mediated Reprint requests to: Naoko Kanda, Department of Dermatology, Teikyo University, School of Medicine, 11-1, Kaga-2, Itabashi-Ku,Tokyo 173 -8605, Japan; Email: nmk@med.teikyo-u.ac.jp Abbreviations: AG1478, 4 -(3 -chloroanilino)-6,7-dimethoxyquinazoline; AP-1, activator protein 1; EMSA, electrophoretic mobility shift assay; ERK, extracellular signal-regulated kinase; G-protein, guanine nucleotide-binding protein; H-89, N-[2-((p-bromocinnamyl) aminoethyl)-5-isoquinolinesulfonamide; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; TRE, TPA response element; U73122, 1-[6 -((17b-3 -methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-dione. signals regulate cytokine or chemokine gene expression in target cells (Kanda and Watanabe, 2002) .
In this study, we examined the e¡ects of histamine on NGF production in cultured human keratinocytes. We found that histamine potentiates NGF production in keratinocytes via H1 receptors. We further examined the precise mechanism for this e¡ect focusing on the histamine-induced intracellular signaling pathways.
MATERIALS AND METHODS
Reagents Histamine dihydrochloride, cimetidine, pyrilamine, and calphostin C were obtained from Sigma (St Louis, MO). Thioperamide maleate was from Biomol Research Laboratories (Plymouth Meeting, PA). 1- [6-((17b-3-methoxyestra-1,3,5(10)-trien-17-yl 
, and 4 -(3 -chloroanilino)-6, 7-dimethoxyquinazoline (AG1478) were obtained from Calbiochem (La Jolla, CA). Recombinant human tumor necrosis factor a was from R&D Systems (Minneapolis, MN). Antibodies used in the electrophoretic mobility shift assay (EMSA) were from Santa Cruz Biotechnology (Santa Cruz, CA).
Culture of keratinocytes Human neonatal foreskin keratinocytes were cultured in serum-free KGM medium (Clonetics, Walkersville, MD) consisting of basal medium MCDB153 supplemented with 0.5 mg per ml hydrocortisone, 5 ng per ml epidermal growth factor, 5 mg per ml insulin, and 0.5% bovine pituitary extract. The cells in third passage were used.
NGF secretion Keratinocytes (2 Â 10 4 per well) were seeded in triplicate into 24 -well plates in 1 ml KGM and adhered overnight; the medium was then changed to basal KBM depleted of hormones, growth factors, and bovine pituitary extract, and the cells were incubated for 24 h. The medium was removed and the cells were incubated with histamine in KBM for 24 h. The supernatants were assayed for NGF by ELISA (Promega, Madison, WI).
RT-PCR Keratinocytes were incubated as above for indicated periods, and cellular mRNA was extracted using an mRNA puri¢cation kit (Pharmacia, Uppsala, Sweden) according to the manufacturer's instruction. cDNA was made from mRNA samples as described previously (Tjandrawinata et al, 1997) . Primers for ampli¢cation and the sizes of respective PCR products were as follows: NGF, 5 0 -CACACTGAG-GTGCATAGCGT-3 0 -GCAGGGGG-GAGCCAAAAGGG-3 0 and 5 0 -TGCCAGCCCCAGCGTCAAAG-3 0 for 566 bp (Lane et al, 1998; Risse-Hackl et al, 1998; Iannone et al, 2002; Kanda and Watanabe, 2002) . PCR involved one denaturing cycle of 951C for 3 min, 30 cycles of denaturation at 951C for 30 s, annealing at 581C for 30 s, and extension at 721C for 30 s, and a ¢nal extension at 721C for 3 min. The PCR products were analyzed by electrophoresis on 2.5% agarose gels and stained with ethidium bromide, viewed by ultraviolet light. Densitometric analysis was performed by scanning the bands into Photoshop and performing densitometry with NIH Image Software.
Plasmids and transfections
The ¢re£y luciferase reporter plasmids driven by human NGF promoter (^600/ þ 250 bp relative to the transcriptional start site) were constructed by PCR and insertion into pGL3 basic vector (Promega) as described previously (Cartwright et al, 1992) , and are denoted pNGF luc. Site-speci¢c mutation of the promoter was created by multiple rounds of PCR using primers with altered bases as described previously (Li and Kolattukudy, 1994) . p4 Â TPA response element 1 (TRE1)-TATA-luc and p4 Â TRE2-TATA-luc were constructed by inserting four copies of TRE1 (5 0 -GCGTGTGACTCAGGAGT-3 0 , consensus sequence underlined) or TRE2 (5 0 -AGCGGTGAGTCA-GGCTG-3 0 ) from human NGF promoter in front of the TATA box upstream of ¢re£y luciferase reporter as described previously (Kanda and Watanabe, in press ). Transient transfections were performed with E¡ectene (Qiagen, Tokyo, Japan) as described previously (Zellmer et al, 2001) . The e⁄ciency of transfection into keratinocytes by this method was 28.5%73.1% (mean7SEM, n ¼ 9) as determined by £ow cytometry using b-galactosidase vector. E¡ectene produced a higher transfection e⁄ciency than Lipofectin (8.1%71.2%), Lipofectamine (9.5%71.1%), or polybrene-dimethylsulfoxide (8.5%70.9%), and thus was adopted in this study. Keratinocytes were plated in 10 cm dishes and grown to about 60% con£uence. Twenty-four hours before the transfection, the medium was changed to KBM. Keratinocytes were incubated for 6 h with 5 mg of pNGF luc or p4 Â TRE1-TATA-luc or p4 Â TRE2-TATA-luc and 1 mg of Rous sarcoma virus b-galactosidase vector (pRSV-b-gal), premixed with enhancer, transfection bu¡er, and E¡ectene. The transfected cells were washed and incubated in KBM for 18 h and then treated with histamine. After 6 h, cell extracts were prepared and luciferase activities were quanti¢ed using the luciferase assay system (Promega). The same cell extracts were assayed for b-galactosidase activity using the chemiluminescent Galacto-Light kit (Tropix, Bedford, MA). All readings were taken using a Lumat 9501 luminometer (Berthold, Wildbach, Germany). The results obtained in each transfection were normalized for b-galactosidase activity and expressed as relative luciferase activity.
EMSA EMSA was performed as described previously (Cartwright et al, 1992) . The probes used were 32 P-labeled annealed double-stranded DNA containing TRE1 or TRE2 from human NGF promoter. The sequence of the TRE1 probe is 5 0 -ATTTGGAGCGTGTGACTCAGGAGTACGGGAG-3 0 (consensus sequence underlined) and that of the TRE2 probe is 5 0 -GGAGCGCAGCGGTGAGTCAGGCTGCCCCGAG-3 0 . For gel shift assays, 2^5 mg of nuclear protein extracts were incubated at room temperature for 5 min with a mixture containing 6 mM HEPES (pH 7.9), 0.4 mM ethylenediamine tetraacetic acid (EDTA), 125 mM KCl, 10% glycerol, 0.05 mg per mL poly dI-dC, 1 mM dithiothreitol, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 10 mM NaF, 50 mg per ml aprotinin, 50 mg per ml leupeptin. One nanogram of labeled probe was added and the reactions were incubated for another 20 min. In antibody supershift experiments, the nuclear extracts were preincubated with various antibodies for 30 min before the addition of probe. Reactions were then fractionated on a nondenaturing 5% polyacrylamide gel, and visualized with phosphorimager (Molecular Dynamics, Sunnyvale, CA).
Western blot analysis The dual threonine/tyrosine phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) was assessed by western blot as described previously (Gee et al, 2002) . Keratinocytes were incubated with 10^6 M histamine or 10 ng per mL tumor necrosis factor a for 10 min. The cells were lyzed with lysis bu¡er (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 100 mM NaF, 100 mM sodium orthovanadate, and 1 mM ethyleneglycol-bis(b-aminoethyl ether)-N,N,N 0 ,N 0 -tetraacetic acid (EGTA, pH 7.7)) and centrifuged for 20 min at 14,000 Â g at 41C. The supernatant proteins were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. The membrane was blocked and incubated with antiphospho-ERK1/2 or antiphospho-JNK antibodies (Santa Cruz Biotechnology) or antiphospho-p38 antibody (New England Biolabs, Mississauga, Ontario, Canada), followed by peroxidase-conjugated secondary antibodies (BioRad, Hercules, CA). The blots were developed with an enhanced chemiluminescence kit (Amersham, Arlington Heights, IL). The blots were stripped and reprobed with rabbit polyclonal antibodies speci¢c for each of unphosphorylated ERK1/2, JNK, and p38 MAPK (Santa Cruz Biotechnology), as described above.
Assays of PKC PKC activity was analyzed as described previously (Migliaccio et al, 1998) . Keratinocytes were incubated with 10^6 M histamine for 10 min. The cells were harvested and homogenized in a bu¡er containing 20 mM TrisÀHCl (pH 7.4), 2 mM EDTA, 10 mM EGTA, 250 mM sucrose, 5 mM dithiothreitol, 1 mM phenylmethylsulfonyl £uoride, and 0.24 mM leupeptin. Nuclei and debris were removed from the samples by centrifugation (500 Â g, 5 min) and this post nuclear fraction was then centrifuged (105,000 Â g, 90 min). The supernatant was saved as the cytosolic fraction. The pellet was homogenized in the same bu¡er, except for containing 0.1% Triton X-100. The samples were mixed continuously for 1 h at 41C and then centrifuged as described above. This supernatant was saved as the membrane fraction. The cytosolic or membrane fractions were loaded onto columns packed with diethylaminoethyl-sephacel resin and were washed extensively with a solution of 20 mM TrisÀHCl (pH 7.4), 20 mM NaCl, 0.5 mM EDTA, 0.5 mM EGTA, and 10 mM 2-mercaptoethanol. PKC was eluted with the same bu¡er except that the NaCl concentration was increased to 100 mM. Aliquots of puri¢ed PKC from cytosolic or membrane fractions were assayed for protein contents using the Bio-Rad protein determination assay. PKC activity was assessed using a reaction mixture containing 20 mM TrisÀHCl (pH 7.4), 8 mM MgCl 2 , 16 mM ATP, [g-200 mg per ml histone III-S at 301C for 3 min. Activity was determined in the presence or absence of 100 mM CaCl 2 , 8 mg per ml phosphatidyl serine, and 2 mg per ml diolein. Samples were ¢ltered with Whatman GF/C ¢lters, and 32 P incorporation into lysine-rich histone was quanti¢ed by liquid scintillation.
Measurement of histamine release Keratinocytes (2 Â 10 4 per well) were seeded into 24 -well plates in KGM, adhered overnight, and incubated with KBM for 24 h. The medium was replaced with fresh KBM, and the cells were incubated for 24 h. The supernatant histamine amount was measured by ELISA (Cosmo Bio, Tokyo, Japan).
RESULTS
Histamine enhanced NGF secretion in keratinocytes Keratinocytes constitutively secreted a low amount of NGF (21.572.8 pg per ml, mean7SEM, n ¼ 5), and the secretion was concentration-dependently increased by histamine; the stimulatory e¡ect of histamine was manifested at 10^7 M and was maximized at 10^6 M, which increased the secretion 4.5-fold of controls (Fig 1) . The stimulatory e¡ect of histamine was not suppressed by pertussis toxin, indicating that the e¡ect may be mediated via pertussis-toxin-resistant G-proteins. H1 receptor antagonist pyrilamine blocked the stimulatory e¡ect of histamine (Fig 1) whereas H2 antagonist cimetidine (Fig 1) or H3 and H4 antagonist thioperamide (data not shown) did not. These results suggest that H1 receptor but not H2, H3, or H4 receptors may mediate histamine-induced enhancement of NGF secretion in keratinocytes. As 10^6 M of histamine was optimal for NGF induction, this concentration was used in the following experiments.
As examined by ELISA, constitutive histamine secretion by keratinocytes was 9.7570.83 nM (mean7SEM, n ¼ 5), which was less than the threshold (100 nM) for NGF induction (Fig 1) . Pyrilamine, cimetidine, and thioperamide did not reduce the constitutive NGF secretion in the absence of exogenous histamine (data not shown). This suggests that endogenous histamine secreted by keratinocytes may not contribute to NGF secretion. We next examined if histamine may enhance NGF mRNA expression in keratinocytes.
Histamine increased NGF mRNA levels At 3 h of incubation, histamine increased the NGF mRNA level 6.1-fold of controls, which was reversed by pyrilamine but not by cimetidine or pertussis toxin (Fig 2) . Thus histamine increased NGF production via H1 receptors at pretranslational level. We then examined if histamine may enhance NGF promoter activity in keratinocytes.
Histamine enhanced NGF promoter activity It is reported that human NGF gene contains two TREs, TRE1 (^62/^56 bp) and TRE2 ( þ 35/ þ 41 bp), and these may act as enhancer elements for NGF transcription (Cartwright et al, 1992) (Fig 3a) . We transiently transfected NGF promoter (^600/ þ 250 bp) linked to luciferase reporter into human keratinocytes. Histamine treatment increased NGF promoter activity 5.1-fold of controls, and the e¡ect was blocked by pyrilamine (Fig 3b) . The mutation of TRE1 or TRE2 each reduced the basal promoter activity and histamine-induced enhancement of the activity. The mutation of both TRE completely abrogated the basal and histamine-induced promoter activities. These results suggest that both TRE1 and TRE2 may be required for basal and histamine-induced NGF promoter activities. We then analyzed if histamine may enhance transcriptional activities dependent on TRE1 or TRE2.
Histamine enhanced transcription from TRE1 or TRE2 Keratinocytes were transiently transfected with luciferase reporter linked to four repeats of TRE1 or TRE2 in front of the TATA box. Histamine increased the TRE1-or TRE2-dependent transcriptional activities, and the e¡ects were reversed by pyrilamine (Fig 4) . Histamine induced c-Fos/c-Jun binding to TRE It is known that TRE is mostly bound by transcription factor activator protein 1 (AP-1) (Allegretto et al, 1990) . We then examined if histamine may enhance DNA binding of AP-1 at TRE on the NGF promoter. At 1 h of incubation, histamine increased the amount of DNAÀprotein complex with TRE1 probe, and the e¡ect was reversed by pyrilamine (Fig 5, lane 4) . This suggests that histamine may increase transcription factor binding to TRE in keratinocytes via H1 receptors. In unstimulated keratinocytes, anti-c-Jun did but anti-c-Fos antibody did not supershift the complex (Fig 5, lanes 5, 6) , whereas in histaminestimulated keratinocytes both antibodies supershifted the complex (Fig 5, lanes 7, 8) . Antibodies against the other Fos family (FosB, Fra-1, Fra-2) or Jun family (JunB, JunD) proteins did not supershift the complexes by nuclear extracts from unstimulated or histamine-stimulated keratinocytes (data not shown). These results suggest that histamine may shift the AP-1 composition from c-Jun homodimers to c-Fos/c-Jun heterodimers at TRE1. Similar results were obtained by using the TRE2 probe (data not shown).
Histamine induced c-Fos expression in keratinocytes
We then examined if histamine may enhance c-Fos or c-Jun expression in keratinocytes. Histamine rapidly and transiently induced c-Fos mRNA. In unstimulated cells, c-Fos mRNA was undetectable; however, in histamine-stimulated cells, the expression was induced at 15 min, maximized at 30 min, reduced at 1 h, and disappeared at 3 h (Fig 6) . c-Jun mRNA expression was constitutively detectable and was not enhanced by histamine. The results indicate that histamine-induced NGF production may be mainly attributable to the induction of c-Fos expression.
PLC^PKC^MAPK kinase 1 (MEK1)^ERK pathway is involved in histamine-induced NGF production and c-Fos expression Histamine is known to induce various intracellular signaling pathways: the PLCÀPKC pathway leading to the activation of ERK (Megson et al, 2001) or the adenylate cyclaseÀprotein kinase A pathway (Shayo et al, 1997) . We thus tried to identify the signaling pathway involved in histamineinduced enhancement of NGF production. PKC inhibitor calphostin C completely suppressed histamine-induced enhancement of NGF promoter activity (Fig 7a) , NGF secretion (Fig 7b) , TRE1-dependent transcriptional activity (Fig 7c) , and c-Fos expression (Fig 7d) . Histamine-induced c-Fos expression was also completely inhibited by PD98059, which selectively blocks ERK activity by inhibiting MEK1 to phosphorylate ERK1/2 (Fig 7d) . PD98059 also suppressed histamineinduced enhancement of NGF promoter activity (Fig 7a) , NGF secretion (Fig 7b) , and TRE1-dependent transcriptional activity (Fig 7c) by 60%^65%. These results suggest the requirement of PKC and ERK for histamine-induced enhancement of NGF production. In contrast, histamineinduced NGF promoter activation, NGF secretion, TRE1-dependent transcriptional activity, and c-Fos expression were not suppressed by protein kinase A inhibitor H-89, indicating that protein kinase A may be dispensable for the histamineinduced e¡ects. We then examined if histamine may activate PKC or ERK in keratinocytes. In unstimulated keratinocytes, most PKC activity resided in the cytosolic fraction (Fig 8a) . At 10 min after histamine treatment, PKC activity in the membrane fraction was enhanced, indicating the membrane translocation of PKC. Pyrilamine and PLC inhibitor U73122 suppressed the histamine-induced enhancement of PKC activity in the membrane whereas cimetidine and pertussis toxin did not (Fig 8b) . These results suggest that histamine-induced membrane translocation of PKC may be mediated via H1 receptor and PLC but may be independent of H2 receptor and insensitive to pertussis toxin. ERK is known to be activated by MEK1 via dual phosphorylation on threonine and tyrosine residues (Widmann et al, 1999) . We thus examined the phosphorylation status of ERK after histamine treatment. At 10 min, histamine induced dual phosphorylation of ERK1 (44 kDa) and ERK2 (42 kDa) (Fig 9a) , and the phosphorylation was suppressed by calphostin C, PD98059, and pyrilamine, indicating that histamine-induced ERK activation may require PKC, MEK1 activity and may be mediated via H1 receptor. Recent studies have demonstrated that certain G-proteincoupled receptors activate ERK via transactivation of epidermal growth factor receptor tyrosine kinase (Zwick et al, 1999 ). This possibility is rather unlikely in histamine-stimulated keratinocytes, however, as AG1478, an inhibitor of epidermal growth factor receptor tyrosine kinase, did not block histamineinduced ERK phosphorylation (Fig 9a) . In contrast to ERK, histamine did not stimulate the dual phosphorylation of other MAPKs, JNK, and p38 MAPK in keratinocytes (Fig 9b, c) .
DISCUSSION
In this study, histamine enhanced NGF production in human keratinocytes via H1 receptors, which is consistent with previous studies on rat astrocytes (Lipnik-Strangelj et al, 1998; LipnikStrangelj and Carman-Krzan, 2000; . Histamine stimulated NGF transcription in keratinocytes by enhancing transcriptional activity of AP-1. Histamine induced rapid and transient c-Fos mRNA expression. The induced c-Fos may heterodimerize with c-Jun and the heterodimers may bind to two TREs on NGF promoter and drive NGF transcription. On the other hand, c-Jun homodimers appeared to bind to TRE in unstimulated keratinocytes. It is reported that c-Fos/c-Jun heterodimers much more avidly bind to DNA and have much higher transcriptional activity than c-Jun homodimers (Allegretto et al, 1990; Suzuki et al, 1991) . Thus histamine may enhance AP-1 binding and transcriptional activity by inducing c-Fos expression and thus shifting Histamine-induced c-Fos expression was mediated via ERK activation, which is consistent with the previous study (Megson et al, 2001) . c-fos promoter contains serum response element where ternary complex factors like Elk1 are binding (Janknecht et al, 1995; Soh et al, 1999) . It is known that ERK-mediated phosphorylation of Elk1 promotes its transcriptional activity (Marais et al, 1993) . It is thus anticipated that Elk1 phosphorylation by ERK may be involved in histamine-induced c-Fos expression. Histamine-induced activation of ERK was dependent on H1 receptor, PKC, and MEK1 (Fig 9a) . It is reported that the activation of H1 receptor leads to the stimulation of PLCb, which generates diacylglycerol that activates PKC (Hill et al, 1997) . PKC is known to phosphorylate and activate c-Raf (Kolch et al, 1993) , and the activated c-Raf may further phosphorylate and activate MEK1 catalyzing ERK phosphorylation. Thus the activation of H1 receptor may trigger the signaling cascade of PLCÀPKCÀc-RafÀMEK1ÀERK, and resultantly induce c-fos transcription. The activation of this cascade is insensitive to pertussis toxin, indicating that pertussis-toxin-insensitive G-proteins like G q/11 may link H1 receptors to PLC in keratinocytes. In certain cell types, H2 receptor, as well as H1 receptor, is known to be linked to PLC activation (Del Valle and Ganz, 1997). In keratinocytes, however, H2 receptor may not be functionally linked to the PLCÀPKC pathway as cimetidine did not inhibit PKC activation by histamine (Fig 8b) .
In monocytic U937 cells, histamine induces c-fos transcription by stimulating H2 receptor linked to the adenylate cyclaseÀ protein kinase A pathway (Shayo et al, 1997) . c-fos promoter contains cAMP response element, where cAMP-response-elementbinding protein binds and drives c-fos transcription (Janknecht et al, 1995) . The transcriptional activity of cAMP-responseelement-binding protein is promoted via phosphorylation by cAMP-dependent protein kinase A (Lalli and Sassone-Corsi, 1994) . Protein kinase A was dispensable for histamine-induced cFos expression in keratinocytes, however (Fig 7) . Thus the mechanism for c-Fos induction by histamine appears to vary with cell type. This is possibly due to the cell type speci¢city in relative expression of histamine receptor isotypes and the amounts, activities, or receptor-coupling status of G-protein subfamilies.
MEK1 inhibitor PD98059 completely inhibited histamineinduced c-Fos expression whereas its inhibition on NGF production and AP-1 transcriptional activity was incomplete (Fig  7) . On the other hand, these were completely inhibited by PKC inhibitor calphostin C (Fig 7) . This indicates that PKC may c-Fos-and ERK-independently stimulate AP-1 activity and NGF production. PKC is known to enhance the DNA binding , and then reprobed with anti-JNK or anti-p38 antibodies (lower panels), respectively. As a positive control, keratinocytes were incubated with 10 ng per ml tumor necrosis factor a (TNF-a) for 10 min, and were analyzed as above. The results shown in the ¢gure are representative of ¢ve separate experiments.
activity of c-Jun by dephosphorylating serine residues adjacent to the DNA binding domain (Boyle et al, 1991; Goode et al, 1992) , which may be the e¡ect independent from ERK and c-Fos.
In contrast to c-Fos, c-Jun mRNA level was not increased by histamine (Fig 6) , which may be because histamine failed to activate JNK (Fig 9b) , which phosphorylates c-Jun at N-terminal serine residues. c-jun promoter contains atypical TRE where c-Jun/activating transcription factor 2 heterodimer constitutively binds, and phosphorylation of the heterodimer by JNK enhances c-jun transcription (Karin, 1995) . Though JNK increases transcriptional activity of c-Jun, JNK may not be involved in histamineinduced activation of AP-1 in keratinocytes. Robinson and Dickenson (2001) also reported that histamine did not activate JNK in hamster smooth muscle cell line DDT 1 MF-2. On the other hand, histamine activated JNK in H2-receptor-transfected human embryonic kidney cells (Wang et al, 2000) . Thus JNK regulation via H1 or H2 receptor may vary depending on cell type.
The level of endogenous histamine produced by keratinocytes was less than threshold (10^7 M) for NGF induction. More than threshold level of histamine in vivo may possibly be derived from mast cells accumulated in the dermis of in£ammatory skin lesions. Thus histamine released from mast cells may induce keratinocytes to produce NGF, and the induced NGF may in turn promote histamine release from mast cells. Such a positive feedback loop of histamine/NGF may amplify in vivo skin in£ammat-ion as NGF induces neurons to synthesize immunomodulatory neuropeptides like substance P or calcitonin-gene-related peptide (Linsay and Harmar, 1989) , or induces keratinocytes to produce in£ammatory cytokines or chemokines (Raychaudhuri et al, 2000) , or enhances the survival or proliferation of neutrophils and T cells (Toyoda et al, 2002) . H1 receptor antagonist may inhibit histamine-induced NGF production and thus block the in£ammation, epidermal hyperplasia, and hyperinnervation in in£ammatory skin lesions like psoriasis, atopic dermatitis, or allergic contact dermatitis. As coculture with murine 3T3 ¢broblasts increased constitutive NGF secretion by human keratinocytes approximately 8-fold compared to controls in our preliminary experiments, we are now studying whether histamine may also increase NGF production in the coculture system, which is more relevant to in vivo skin morphology.
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